Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks

PHASE3CompletedINTERVENTIONAL
Enrollment

318

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

June 30, 2010

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Indacaterol

Once daily via single-dose dry powder inhaler (SDDPI)

DRUG

Placebo to indacaterol

Once daily via SDDPI

Trial Locations (54)

23229

Novartis Investigative Site, Richmond

27607

Novartis Investigative Site, Raleigh

28152

Novartis Investigative Site, Shelby

28207

Novartis Investigative Site, Charlotte

29303

Novartis Investigative Site, Spartanburg

29379

Novartis Investigative Site, Union

29406

Novartis Investigative Site, North Charleston

29407

Novartis Investigative Site, Charleston

29412

Novartis Investigative Site, Charleston

29615

Novartis Investigative site, Greenville

29640

Novartis Investigative Site, Easley

30342

Novartis Investigative Site, Atlanta

32789

Novartis Investigative Site, Winter Park

33021

Novartis Investigative Site, Hollywood

33145

Novartis Investigative site, Miami

33603

Novartis Investigative Site, Tampa

33756

Novartis Investigative Site, Clearwater

33765

Novartis Investigative Site, Clearwater

35501

Novartis Investigative Site, Jasper

42431

Novartis Investigative Site, Madisonville

43213

Novartis Investigative Site, Columbus

43215

Novartis Investigative Site, Columbus

43302

Novartis Investigator Site, Marion

44718

Novartis Investigative Site, Canton

45242

Novartis Investigator Site, Cincinnati

52242

Novartis Investigator Site, Iowa City

61761

Novartis Investigator Site, Normal

63141

Novartis Investigator Site, St Louis

63301

Novartis Investigator Site, Saint Charles

68114

Novartis Investigator Site, Omaha

68134

Novartis Investigator Site, Omaha

68510

Novartis Investigator Site, Lincoln

70570

Novartis Investigator Site, Opelousas

70808

Novartis Investigator Site, Baton Rouge

75069

Novartis Investigator Site, McKinney

76012

Novartis Investigator Site, Arlington

77539

Novartis Investigator Site, Dickinson

79903

Novartis Investigator Site, El Paso

85006

Novartis Investigator Site, Phoenix

85306

Novartis Investigator Site, Glendale

87108

Novartis Investigator Site, Albuquerque

89014

Novartis Investigator Site, Henderson

89119

Novartis Investigator Site, Las Vegas

90048

Novartis Investigator Site, Los Angeles

90095

Novartis Investigator Site, Los Angeles

92506

Novartis Investigator Site, Riverside

92835

Novartis Investigator Site, Fullerton

97404

Novartis Investigator Site, Eugene

97504

Novartis Investigator Site, Medford

36207-5710

Novartis Investigative Site, Anniston

08003

Novartis Investigative Site, Cherry Hill

02864

Novartis Investigative Site, Cumberland

02860

Novartis Investigative Site, Pawtucket

05403

Novartis Investigative Site, South Burlington

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY

NCT01068600 - Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks | Biotech Hunter | Biotech Hunter